Kikuchi, Yuki http://orcid.org/0000-0002-1184-8918
Yada, Yuji
Otsuka, Yuji http://orcid.org/0000-0003-4041-7698
Ito, Fumiaki
Tanifuji, Hiroaki
Komatsu, Hiroshi
Tomita, Hiroaki http://orcid.org/0000-0003-2628-880X
Article History
Received: 27 September 2023
Accepted: 10 November 2023
First Online: 20 November 2023
Competing interests
: Y.Y. has received speaker’s fees from Otsuka and Sumitomo Pharma. H.To. has received grant funding (paid to Tohoku University) from Daiichi Sankyo Company, Limited, Eisai Co., Ltd., Otsuka Pharmaceutical Co., Ltd., and Sumitomo Dainippon Pharma Co., Ltd.; and has received personal payment or honoraria from Daiichi Sankyo Company, Limited, EA Pharma Co., Ltd., Eisai Co., Ltd., Janssen Pharmaceutical K.K., Lundbeck, Meiji Seika Pharma Co., Ltd., Mochida Pharmaceutical Co., Ltd., MSD K.K., Mylan EPD G.K., Otsuka Pharmaceutical Co., Ltd., Pfizer Japan Inc., Sumitomo Pharma Co., Ltd., Takeda Pharmaceutical Company Limited, and Viatris Inc. The other authors declare no competing interests.